Abstract:This study demonstrates a molecular mechanism by which normal cells sense and respond to oncogenic stress driven by aberrant ERK activity to prevent tumorigenesis, and how its dysregulation occurs in cancer. In this process, GADD45β, an activator of the MTK1 MAPKKK, is selectively upregulated by oncogenic ERK signaling, leading to the activation of MTK1‐p38/JNK signaling and the induction of apoptosis in normal cells. However, this tumor‐suppressive signaling pathway is frequently inactivated in cancer, thereby promoting tumor progression. The ERK pathway governs essential biological processes such as cell proliferation and survival, and its hyperactivation by various oncogenes ultimately drives carcinogenesis. However, normal mammalian cells typically recognize aberrant ERK signaling as oncogenic stress and respond by inducing cell cycle arrest or apoptosis through activation of the p38 and JNK pathways. Despite the critical role of this response in preventing carcinogenesis, the precise molecular mechanisms underlying oncogene‐induced, ERK‐dependent activation of p38/JNK and its tumor‐suppressive effects remain unclear. Here, we demonstrate that MAP three kinase 1 (MTK1), a stress‐responsive MAPKKK, serves as a key mediator of p38/JNK activation induced by oncogenic ERK signaling. Mechanistically, aberrant ERK signaling induces sustained expression of the transcription factor early growth response protein 1 (EGR1), which promotes the production of the MTK1 activator GADD45β, leading to persistent activation of MTK1‐p38/JNK signaling. Gene knockout and transcriptome analyses revealed that this GADD45β/MTK1‐mediated cross‐talk between the ERK and p38/JNK pathways preferentially upregulates a specific set of genes involved in apoptosis and the immune response. Notably, the expression of EGR1, GADD45β, and MTK1 is frequently downregulated in many cancers with high ERK activity, resulting in the disruption of the tumor‐suppressive ERK‐p38/JNK cross‐talk. Restoring GADD45β expression in cancer cells reactivates p38/JNK signaling and suppresses tumorigenesis. Our findings delineate a molecular mechanism by which normal cells sense and respond to oncogenic stress to prevent abnormal growth, and highlight the significance of its dysregulation in cancer.

TGFβ Activates Mitogen- and Stress-activated Protein Kinase-1 (MSK1) to Attenuate Cell Death

GADD45β‐MTK1 signaling axis mediates oncogenic stress‐induced activation of the p38 and JNK pathways

Transforming Growth Factor-β1 (TGF-β)–induced Apoptosis of Prostate Cancer Cells Involves Smad7-dependent Activation of p38 by TGF-β-activated Kinase 1 and Mitogen-activated Protein Kinase Kinase 3

TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling

Direct Activation of TACE-Mediated Ectodomain Shedding by P38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation

TACE-Mediated Ectodomain Shedding of the Type I TGF-b Receptor Downregulates TGF-b Signaling

P38 Mitogen-Activated Protein Kinase Pathway Suppresses Cell Survival By Inducing Dephosphorylation Of Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

Editor's Note: P38 Mitogen-activated Protein Kinase Pathway Suppresses Cell Survival by Inducing Dephosphorylation of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase1,2

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis

Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and P38 Signaling Pathways

Requirement for Transforming Growth Factor Β1 in Controlling T Cell Apoptosis

TGF-b1 Induces Endothelial Cell Apoptosis by Shifting VEGF Activation of p38 from the Prosurvival p38b to Proapoptotic p38a

Regulation of Cell Proliferation by Smad Proteins

JNK-Dependent cJun Phosphorylation Mitigates TGFβ- and EGF-Induced Pre-Malignant Breast Cancer Cell Invasion by Suppressing AP-1-Mediated Transcriptional Responses.

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

DAPK Mediates TNF‐alpha Induced Apoptosis by TNF‐receptor 1 Association and JNK Activation Through MKK7

MAPK Phosphatase-5 is required for TGF-β signaling through a JNK-dependent pathway

Regulation of Smad signaling by protein kinase C.